Foto del docente

Michele Cavo

Professore Alma Mater

Alma Mater Studiorum - Università di Bologna

Professore a contratto a titolo gratuito

Dipartimento di Scienze Mediche e Chirurgiche

Pubblicazioni

Zamagni, Elena; Tacchetti, Paola; Pantani, Lucia; Cavo, Michele, Anti-CD38 and anti-SLAMF7: the future of myeloma immunotherapy, «EXPERT REVIEW OF HEMATOLOGY», 2018, 11, pp. 423 - 435 [articolo]

Garderet, Laurent; Laubach, Jacob P; Stoppa, Anne-Marie; Hari, Parameswaran; Cavo, Michele; Ludwig, Heinz; Mateos, María-Victoria; Luptakova, Katarina; Lin, Jianchang; Yung, Godwin; van de Velde, Helgi; Berg, Deborah; Moreau, Philippe; Richardson, Paul G, Association between response kinetics and outcomes in relapsed/refractory multiple myeloma: analysis from TOURMALINE-MM1, «LEUKEMIA», 2018, 32, pp. 2032 - 2036 [articolo]

Zamagni, Elena; Cavo, Michele; Fakhri, Bita; Vij, Ravi; Roodman, David, Bones in Multiple Myeloma: Imaging and Therapy, in: 2018 ASCO Educational Book, Alexandria, Va, American Society of Clinical Oncology, 2018, pp. 638 - 646 (AMERICAN SOCIETY OF CLINICAL ONCOLOGY EDUCATIONAL BOOK) [capitolo di libro]

D. Sollazzo, D. Forte, G. Simonetti, S. Bruno, M. Barone, G. Auteri, E. Ottaviani, M. Romano, G. Martinelli, N. Vianelli, M. Cavo, F. Palandri, L. Catani, CIRCULATING CD34+ STEM/PROGENITOR CELLS FROM TRIPLE NEGATIVE PATIENTS WITH MYELOFIBROSIS SHOW DIFFERENT NUMBER, GENE EXPRESSION PROFILE AND IN VITRO RESPONSE TO INFLAMMATORY STIMULI AS COMPARED WITH THE JAK2(V617F) MUTATED COUNTERPARTS, in: Haematologica XV Congress of the Italian Society of Experimental Hematology Rimini, Italy, October 18-20, 2018 ABSTRACT BOOK, 2018(atti di: XV Congress of the Italian Society of Experimental Hematology, Rimini, Italy, October 18-20, 2018) [atti di convegno-poster]

Bringhen, Sara; Milan, Alberto; Ferri, Claudio; Wäsch, Ralph; Gay, Francesca; Larocca, Alessandra; Salvini, Marco; Terpos, Evangelos; Goldschmidt, Hartmut; Cavo, Michele; Petrucci, Maria Teresa; Ludwig, Heinz; Auner, Holger W; Caers, Jo; Gramatzki, Martin; Boccadoro, Mario; Einsele, Hermann; Sonneveld, Pieter; Engelhardt, Monika, Cardiovascular adverse events in modern myeloma therapy - Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA), «HAEMATOLOGICA», 2018, 103, pp. 1422 - 1432 [articolo]Open Access

Fontana, Maria Chiara*; Marconi, Giovanni; Feenstra, Jelena D. Milosevic; Fonzi, Eugenio; Papayannidis, Cristina; Ghelli Luserna Di Rorá, Andrea; Padella, Antonella; Solli, Vincenza; Franchini, Eugenia; Ottaviani, Emanuela; Ferrari, Anna; Baldazzi, Carmen; Testoni, Nicoletta; Iacobucci, Ilaria; Soverini, Simona; Haferlach, Torsten; Guadagnuolo, Viviana; Semerad, Lukas; Doubek, Michael; Steurer, Michael; Racil, Zdenek; Paolini, Stefania; Manfrini, Marco; Cavo, Michele; Simonetti, Giorgia; Kralovics, Robert; Martinelli, Giovanni, Chromothripsis in acute myeloid leukemia: Biological features and impact on survival, «LEUKEMIA», 2018, 32, pp. 1609 - 1620 [articolo]Open Access

Soverini, Simona; Mancini, Manuela; Bavaro, Luana; Cavo, Michele; Martinelli, Giovanni, Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy, «MOLECULAR CANCER», 2018, 17, pp. 1 - 15 [articolo]Open Access

Stefoni, Vittorio; Broccoli, Alessandro; Argnani, Lisa; Sabattini, Elena; Cavo, Michele; Zinzani, Pier Luigi, Clinical Features and Treatment Outcomes of Primary Cutaneous B-cell Lymphomas: A Thirty-year Experience, «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2018, 18, pp. 297 - 299 [articolo]

Usmani, Saad Z; Hoering, Antje; Cavo, Michele; Miguel, Jesus San; Goldschimdt, Hartmut; Hajek, Roman; Turesson, Ingemar; Lahuerta, Juan Jose; Attal, Michel; Barlogie, Bart; Lee, Jae Hoon; Kumar, Shaji; Lenhoff, Stig; Morgan, Gareth; Rajkumar, S Vincent; Durie, Brian G M; Moreau, Philippe, Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research Project, «BLOOD CANCER JOURNAL», 2018, 8, pp. 123 - 123 [articolo]Open Access

Latagliata, Roberto; Polverelli, Nicola; Tieghi, Alessia; Palumbo, Giuseppe Alberto; Breccia, Massimo; Sabattini, Elena; Villari, Loredana; Riminucci, Mara; Valli, Riccardo; Catani, Lucia; Alimena, Giuliana; Ottaviani, Emanuela; Fama, Angelo; Martinelli, Giovanni; Perricone, Margherita; Spinsanti, Marco; Cavo, Michele; Vianelli, Nicola; Palandri, Francesca, Comparison of JAK2V617F-positive essential thrombocythaemia and early primary myelofibrosis: The impact of mutation burden and histology, «HEMATOLOGICAL ONCOLOGY», 2018, 36, pp. 269 - 275 [articolo]

Musto, P; Anderson, K. C; Attal, M; Richardson, P. G; Badros, A; Hou, J; Comenzo, R; Du, J; Durie, B. G. M; San Miguel, J; Einsele, H; Chen, W. M; Garderet, L; Pietrantuono, G; Hillengass, J; Kyle, R. A; Moreau, P; Lahuerta, J. J; Landgren, O; Ludwig, H; Larocca, A; Mahindra, A; Cavo, M; Mazumder, A; Mccarthy, P. L; Nouel, A; Rajkumar, S. V; Reiman, A; E, Riva; Sezer, O; Terpos, E; Turesson, I; Usmani, S; Weiss, B. M; Palumbo, A., Corrigendum: Second primary malignancies in multiple myeloma: an overview and IMWG consensus, «ANNALS OF ONCOLOGY», 2018, 29, pp. 1074 - 1074 [articolo]

Mateos, María-Victoria; Dimopoulos, Meletios A; Cavo, Michele; Suzuki, Kenshi; Jakubowiak, Andrzej; Knop, Stefan; Doyen, Chantal; Lucio, Paulo; Nagy, Zsolt; Kaplan, Polina; Pour, Ludek; Cook, Mark; Grosicki, Sebastian; Crepaldi, Andre; Liberati, Anna M; Campbell, Philip; Shelekhova, Tatiana; Yoon, Sung-Soo; Iosava, Genadi; Fujisaki, Tomoaki; Garg, Mamta; Chiu, Christopher; Wang, Jianping; Carson, Robin; Crist, Wendy; Deraedt, William; Nguyen, Huong; Ming, Qi; San-Miguel, Jesus for the ALCYONE Trial Investigators, Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma, «THE NEW ENGLAND JOURNAL OF MEDICINE», 2018, 378, pp. 518 - 528 [articolo]

Spencer, Andrew; Lentzsch, Suzanne; Weisel, Katja; Avet-Loiseau, Hervé; Mark, Tomer M; Spicka, Ivan; Masszi, Tamas; Lauri, Birgitta; Levin, Mark-David; Bosi, Alberto; Hungria, Vania; Cavo, Michele; Lee, Je-Jung; Nooka, Ajay K; Quach, Hang; Lee, Cindy; Barreto, Wolney; Corradini, Paolo; Min, Chang-Ki; Scott, Emma C; Chanan-Khan, Asher A; Horvath, Noemi; Capra, Marcelo; Beksac, Meral; Ovilla, Roberto; Jo, Jae-Cheol; Shin, Ho-Jin; Sonneveld, Pieter; Soong, David; Casneuf, Tineke; Chiu, Christopher; Amin, Himal; Qi, Ming; Thiyagarajah, Piruntha; Sasser, A Kate; Schecter, Jordan M; Mateos, Maria-Victoria, Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR, «HAEMATOLOGICA», 2018, 103, pp. 2079 - 2087 [articolo]Open Access

Palandri F, Palumbo GA, Iurlo A, Polverelli N, Benevolo G, Breccia M, Abruzzese E, Tiribelli M, Bonifacio M, Tieghi A, Isidori A, Martino B, Sgherza N, D'Adda M, Bergamaschi M, Crugnola M, Cavazzini F, Bosi C, Binotto G, Auteri G, Latagliata R, Ibatici A, Scaffidi L, Penna D, Cattaneo D, Soci F, Trawinska M, Russo D, Cuneo A, Semenzato G, Di Raimondo F, Aversa F, Lemoli RM, Heidel F, Reggiani MLB, Bartoletti D, Cavo M, Catani L, Vianelli N., Differences in presenting features, outcome and prognostic models in patients with primary myelofibrosis and post-polycythemia vera and/or post-essential thrombocythemia myelofibrosis treated with ruxolitinib. New perspective of the MYSEC-PM in a large multicenter study⁎, «SEMINARS IN HEMATOLOGY», 2018, 55, pp. 248 - 255 [articolo]Open Access

Palandri, Francesca; Palumbo, Giuseppe A; Bonifacio, Massimiliano; Breccia, Massimo; Latagliata, Roberto; Martino, Bruno; Polverelli, Nicola; Abruzzese, Elisabetta; Tiribelli, Mario; Nicolosi, Maura; Bergamaschi, Micaela; Tieghi, Alessia; Iurlo, Alessandra; Sgherza, Nicola; Cavazzini, Francesco; Isidori, Alessandro; Binotto, Gianni; Ibatici, Adalberto; Crugnola, Monica; Heidel, Florian; Bosi, Costanza; Bartoletti, Daniela; Auteri, Giuseppe; Catani, Lucia; Cuneo, Antonio; Aversa, Franco; Semenzato, Gianpietro; Cavo, Michele; Vianelli, Nicola; Benevolo, Giulia, Durability of spleen response affects the outcome of ruxolitinib-treated patients with myelofibrosis: Results from a multicentre study on 284 patients, «LEUKEMIA RESEARCH», 2018, 74, pp. 86 - 88 [articolo]